XML 207 R87.htm IDEA: XBRL DOCUMENT v3.22.1
Commissions and expenses (Tables)
12 Months Ended
Dec. 31, 2021
Statement [LineItems]  
Summary of Commissions and Expenses
 
 
 
 
 
 
 
 
 
 
 
 
 
 
       
     
                2021
                    2020                     2019  
       
Commissions
     2,562       2,283       2,423  
       
Employee expenses
     1,897       1,995       2,149  
       
Administration expenses
     1,581       1,593       1,537  
       
Deferred expenses
     (1,160     (741     (832
       
Amortization of deferred expenses
     933       767       755  
       
Amortization of VOBA and future servicing rights
     171       87       120  
       
Total
  
 
5,984
 
 
 
5,983
 
 
 
6,153
 
       
Included in administration expenses:
                        
       
Depreciation of equipment, software and real estate held for own use
     99       101       87  
Summary of Employee Expenses
 
 
 
 
 
 
 
 
 
 
 
 
 
 
       
Employee expenses
  
                2021
                    2020                     2019  
       
Salaries
     1,300        1,316        1,321   
       
Post-employment benefit costs
     172       199       287  
       
Social security charges
     128       125       127  
       
Other personnel costs
     254       318       378  
       
Shares
     44       37       36  
       
Total
  
 
1,897
 
 
 
1,995
 
 
 
2,149
 
       
Included in employee expenses:
                        
       
Defined contribution expenses
     35       36       43  
Summary of Cumulative Number of Shares and Their Status in Relation to Active Long Term Incentive Plans and Allocated Variable Compensation to Identified Staff
The following overview contains the cumulative number of shares and their status in relation to active Long Term Incentive Plans, variable compensation allocated to Material Risk Takers, shares allocated as fixed compensation and shares allocated as part of a sign-on arrangement.
Number of shares per plan year
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
             
              2017              2018              2019              2020     
        2021
             Total    
             
Conditionally granted
1)
     6,722,418        6,513,984        7,378,113        8,381,086        9,449,451        38,445,052    
             
Allocated
2)
     7,461,564        6,123,546        6,761,360        6,522,324        -        26,868,794    
 
1
The at target number of shares which were conditionally granted for the plan year.
2
The allocated number of shares based on the actual performance during the plan year.
Number of shares per plan year
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
     2017     2018     2019     2020     2021    
Total
 
Unvested at January 1, 2020
  
 
6,516,995
 
 
 
5,663,455
 
 
 
8,330,014
 
 
 
-
 
 
 
-
 
 
 
20,510,464
 
             
Conditionally granted as variable compensation
1)
     -       -       -       8,381,086       -       8,381,086  
             
Allocated
2)
     4,436       38,502       (616,753     954,850       -       381,035  
             
Forfeited
     (55,039     (199,587     (94,970     (17,644     -       (367,240
             
Vested
     (2,604,178     (250,819     (277,523     (66,526     -       (3,199,046
Unvested at December 31, 2020
  
 
3,862,214
 
 
 
5,251,551
 
 
 
7,340,768
 
 
 
9,251,766
 
 
 
-
 
 
 
25,706,299
 
             
Conditionally granted as variable compensation
1)
     -       -       -       -       9,449,451       9,449,451  
             
Allocated
2)
     3,928       4,010       (29,388     (1,858,762     2,450,661       570,449  
             
Forfeited
     (92,665     (205,734     (254,543     (174,128     (4,729     (731,799
             
Vested
     (3,773,477     (2,037,774     (259,858     (221,441     (69,851     (6,362,401
Unvested at December 31, 2021
  
 
-
 
 
 
3,012,053
 
 
 
6,796,979
 
 
 
6,997,435
 
 
 
11,825,532
 
 
 
28,631,999
 
             
Grant price (in EUR)
3)
     5.246       5.405       4.162       4.083       3.2927          
             
       4.040 to       4.143 to       2.741 to       1.794 to       1.625 to          
Fair value of shares at grant date (in EUR)
4)
     4.933       5.054       3.737       3.796       3.978    
 
 
 
 
1
The at target number of shares which were conditionally granted as variable compensation for the plan year.
2
Shares allocated in the same year are a combination of shares allocated as fixed compensation and sign-on shares which have been allocated during that year (e.g. the 954,850 shares allocated during the calendar year 2020 in relation to the 2020 plan year). Shares allocated during a calendar year in relation to the previous plan year concerns the difference between the conditionally granted shares for that plan year and the actual number of shares which have been allocated (e.g. the 616,753 share correction during 2020 for the 2019 plan year). This number can therefore be positive or negative. Shares allocated during a calendar year in relation to earlier plan years are backdated corrections to the administration (e.g. during 2020 a correction of 38,502 shares was made to the 2018 plan year).
3
This is the volume weighted average price (VWAP) of Aegon on the Euronext Amsterdam stock exchange for the period December 15 to January 15. For instance for the 2021 plan year, this is the VWAP for the period December 15, 2020 to January 15, 2021.
4
These fair values are adjusted for expected dividend (for which the participants are not eligible during the deferral period) and for the impact of relative total shareholder return as performance indicator for variable compensation (where applicable).
Aegon N.V [member]  
Statement [LineItems]  
Summary of Commissions and Expenses
 
  
  
  
  
                2021 
 
 
                2020
 
       
Employee expenses
          84        86  
       
Administration expenses
          71        58  
       
Cost sharing to group companies
  
 
     (75     (72
       
Total
  
 
  
 
80 
 
 
 
71